Skip to main content
Caplight Logo









Phoenicis Therapeutics

Phoenicis Therapeutics

Private
Hingham, MassachusettsHealthcare & Life Scienceshttps://phoenicistx.com/

Last Round

VC Round

Aug 11, 2022

Company Overview

Phoenicis Therapeutics operates in Healthcare & Life Sciences and is based in Hingham, Massachusetts. Its latest recorded funding round was a VC Round in August 2022.

Phoenicis Therapeutics is a biotechnology company that develops recombinant protein-based therapies for rare, genetic, and inflammatory disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Phoenicis Therapeutics Comparables

Compare Phoenicis Therapeutics with similar companies based on industry and business-model similarity.

Phoenicis Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nova Anchora
86%
CSA Biotechnologies
83%
Aegle Therapeutics Corp
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Phoenicis Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 11, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Phoenicis Therapeutics Investors

Notable investors and investment history

Phoenicis Therapeutics investors
InvestorRounds
CureDuchenne VenturesVC Round
Congressionally Directed Medical Research ProgramsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 11, 2022

    $20M round from Cure EB and others.

Book a demo to see all signals

For institutional investors. Book with your work email.

Phoenicis Therapeutics Filings

Explore SEC and related filing metadata, where available.

Phoenicis Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Phoenicis Therapeutics's valuation, stock price, and market status.

Is Phoenicis Therapeutics a public or private company?

Phoenicis Therapeutics is a private company.

What is the current stock price of Phoenicis Therapeutics?

Phoenicis Therapeutics is a private company, so its shares have no public market price. Caplight tracks Phoenicis Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Phoenicis Therapeutics worth (valuation)?

Valuation information for Phoenicis Therapeutics is not publicly available.

Can I buy Phoenicis Therapeutics stock?

Phoenicis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Phoenicis Therapeutics's last funding round?

Phoenicis Therapeutics's most recent funding round was VC Round on August 11, 2022.

Who are the main investors in Phoenicis Therapeutics?

Key investors in Phoenicis Therapeutics include CureDuchenne Ventures, Congressionally Directed Medical Research Programs.

Will Phoenicis Therapeutics IPO soon?

No public IPO plans have been announced for Phoenicis Therapeutics.

How can I track Phoenicis Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in Phoenicis Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersHingham, Massachusetts
Employee Range1
Year Founded2020
Last FundingAug 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?